This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
A. C. Bozoki , H. An , E. S. Bozoki and R. J. Little (2009). The existence of cognitive plateaus in Alzheimer's disease. Alzheimer's and Dementia, 5, 470–478.
M. J. Chandler et al. (2005). A total score for the CERAD neuropsychological battery. Neurology, 65, 102–106.
F. Cortes et al. (2008). Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR study. Alzheimer's and Dementia, 4, 22–29.
J. L. Cummings , M. Mega , K. Gray , S. Rosenberg-Thompson , D. A. Carusi and J. Gornbein (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308–2314.
J. L. Cummings , E. Schneider , P. N. Tariot and S. M. Graham (2006). Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology, 67, 57–63.
H. H. Feldman , B. Van Baelen , S. M. Kavanagh and K. E. Torfs (2005). Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis. Alzheimer Disease and Associated Disorders, 19, 29–36.
M. F. Folstein , S. E. Folstein and P. R. McHugh (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
D. Galasko et al. (1997). An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's disease cooperative study. Alzheimer Disease and Associated Disorders, 11 (Suppl. 2), S33–39.
I. Hallikainen et al. (2012). Cognitive and neuropsychiatric symptom differences in early stages of Alzheimer's disease: Kuopio ALSOVA study. Dementia and Geriatric Cognitive Disorders Extra, 2, 209–218. doi:10.1159/000338231.
C. P. Hughes , L. Berg , W. L. Danziger , L. A. Coben and R. L. Martin (1982). A new clinical scale for the staging of dementia. The British Journal of Psychiatry, 140, 566–572.
K. Karttunen et al. (2011). Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease. International Journal of Geriatric Psychiatry, 26, 473–482. doi:10.1002/gps.2550. Epub 2010 Oct 29.
G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price and E. M. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.
T. McLaughlin et al. (2010). Assessment of potential measures in models of progression in Alzheimer disease. Neurology, 75, 1256–1262.
J. C. Morris (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.
J. C. Morris et al. (1993). The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology, 43, 2457–2465.
H. C. Rossetti , C. Munro Cullum , L. S. Hynan and L. H. Lacritz (2010). The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease. Alzheimer Disease and Associated Disorders, 24, 138–142.
S. Salloway et al. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology, 73, 2061–2070.
E. H. Seo et al. (2010). Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies. The American Journal of Geriatric Psychiatry, 18, 801–809.
L. Serra et al. (2010). Relationship between cognitive impairment and behavioural disturbances in Alzheimer's disease patients. Behavioural Neurology, 23, 123–130.
J. Stein et al. (2012). The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German study on ageing, cognition, and dementia in primary care patients (AgeCoDe). The American Journal of Geriatric Psychiatry, 20, 84–97.
M. Steinberg et al. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry, 23, 170–177.
R. E. Tractenberg , M. F. Weiner , J. L. Cummings , M. B. Patterson and L. J. Thal (2005). Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach. The Journal of Neuropsychiatry and Clinical Neurosciences, 17, 51–60.
T. H. Välimäki , K. M. Vehviläinen-Julkunen , A. M. Pietilä and T. A. Pirttilä (2009). Caregiver depression is associated with a low sense of coherence and health-related quality of life. Aging and Mental Health, 13, 799–807.
K. A. Welsh et al. (1994). The consortium to establish a registry for Alzheimer's disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology, 44, 609–614.